{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:19:23Z","timestamp":1789229963437,"version":"build-2803163510"},"reference-count":31,"publisher":"BMJ","issue":"6900","license":[{"start":{"date-parts":[[1993,8,7]],"date-time":"1993-08-07T00:00:00Z","timestamp":744681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1993,8,7]]},"abstract":"<jats:p>OBJECTIVE--To record prognosis and determinants of outcome in patients with acute myocardial infarction since thrombolysis was introduced. DESIGN--Observational study. SETTING--London district general hospital. PATIENTS--608 consecutive patients admitted to the coronary care unit with acute myocardial infarction between 1 January 1988 and 31 December 1991. MAIN OUTCOME MEASURE--All cause mortality, non-fatal ischaemic events (myocardial infarction, unstable angina), and revascularisation. RESULTS--Of the 608 patients, 89 (14.6%) died in hospital. 507 [corrected] patients were followed up after discharge from hospital. Mortality (95% confidence interval) at 30 days, one year, and three years was 16.0% (13.4% to 19.2%), 21.7% (18.6% to 25.2%), and 29.4% (25.3% to 33.9%) respectively. Event free survival (survival without a non-fatal ischaemic event) was 80.4% (77.0% to 83.4%) at 30 days, 66.8% (62.8% to 70.5%) at one year, and 56.1% (51.3% to 60.6%) at three years. Survival in patients treated with thrombolysis was considerably higher than in those not given thrombolysis (three year survival: 76.7% v 54.3%), although the incidence of non-fatal ischaemic events was the same in the two groups. Multivariate determinants of six month survival were left ventricular failure, treatment with thrombolysis and aspirin, smoking history, bundle branch block, and age. For patients who survived six months, age was the only factor related to long term survival. CONCLUSIONS--Although patients treated by thrombolysis had a relatively good prognosis, long term mortality and the incidence of non-fatal recurrent ischaemic events remained high. Effective strategies for the identification and treatment of high risk patients need to be reassessed.<\/jats:p>","DOI":"10.1136\/bmj.307.6900.349","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T08:16:37Z","timestamp":1238400997000},"page":"349-353","source":"Crossref","is-referenced-by-count":111,"title":["Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis."],"prefix":"10.1136","volume":"307","author":[{"given":"R","family":"Stevenson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Ranjadayalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A D","family":"Timmis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1993,8,7]]},"reference":[{"key":"ref_1","first-page":"172","article-title":"et al Trends in survival of hospitalised myocardial infarction patients between 1970 and 1985","volume-title":"The Minnesota heart survey. Circulation","volume":"85","author":"McGovern, P.G.; Folsom, A.R.; Sprafka, M.; Burke, G.L.; Doliszny, K.M.; Demirovic, J.","year":"1992","unstructured":"McGovern PG, Folsom AR, Sprafka M, Burke GL, Doliszny KM, Demirovic J, et al Trends in survival of hospitalised myocardial infarction patients between 1970 and 1985. The Minnesota heart survey. Circulation 1992;85: 172-9."},{"key":"ref_2","first-page":"10","article-title":"The statistical analysis of failure time data","author":"Kalbfleisch, J.D.; Prentice, R.L.","year":"1980","unstructured":"Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. London: John Wiley, 1980;10-9."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables (with discussion). J7ournal of","volume":"34","author":"Cox, DR","year":"1972","unstructured":"Cox DR. Regression models and life tables (with discussion). J7ournal of the Royal Statistical Society [B] 1972;34:187-220.","journal-title":"the Royal Statistical Society [B]"},{"key":"ref_4","first-page":"871","article-title":"Gruppo Italiano per lo Studio della Steptochi nasi nell'Infarcto Miocardico (GISSI). Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI Study","volume":"ii:","year":"1987","unstructured":"Gruppo Italiano per lo Studio della Steptochi nasi nell'Infarcto Miocardico (GISSI). Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI Study. Lancet 1987;ii:871-4.","journal-title":"Lancet"},{"key":"ref_5","first-page":"525","article-title":"Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian study of early thrombolysis (ASSET)","volume":"ii:","author":"Wilcox, R.G.; Olsson, C.G.; Skene, A.M.; Von der Lippe, G.; Jensen, G.; Hampton, JR","year":"1988","unstructured":"Wilcox RG, Olsson CG, Skene AM, Von der Lippe G, Jensen G, Hampton JR. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian study of early thrombolysis (ASSET). Lancet 1988;ii:525-33.","journal-title":"Lancet"},{"key":"ref_6","first-page":"1465","article-title":"The ISAM Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM): mortality, morbidity, and infarct size at 21 days","volume":"314","year":"1986","unstructured":"The ISAM Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM): mortality, morbidity, and infarct size at 21 days. NEnzglJ7Med 1986;314:1465-72."},{"key":"ref_7","first-page":"545","article-title":"Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo controlled clinical trial","volume":"335","author":"Group, A.I.M.S.Trial Study","year":"1990","unstructured":"AIMS Trial Study Group. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo controlled clinical trial. Lancet 1990;335:545-9.","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0140-6736(90)90663-P","article-title":"Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS study","volume":"335","author":"Group, A.I.M.S.Trial Study","year":"1990","unstructured":"AIMS Trial Study Group. Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS study. Lancet 1990;335:427-3 1.","journal-title":"Lancet"},{"key":"ref_9","first-page":"578","article-title":"Improved survival after early thrombolysis in acute myocardial infarction","volume":"ii:","author":"Simoons, M.L.; Serruys, P.W.; Brand, M.; Bars, F.; De Zwaans, C.; Res, J.","year":"1985","unstructured":"Simoons ML, Serruys PW, Brand M, Bars F, De Zwaans C, Res J, et al. Improved survival after early thrombolysis in acute myocardial infarction. Lancet 1985;ii:578-82.","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/01.CIR.73.2.338","article-title":"Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial","volume":"73","author":"Williams, D.O.; Borer, J.; Braunwauld, E.; Chesebro, J.H.; Cohen, I.S.; Dalen, J.","year":"1986","unstructured":"Williams DO, Borer J, Braunwauld E, Chesebro JH, Cohen IS, Dalen J, et al. Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial. Circulation 1986;73:338-46.","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/01.CIR.69.5.991","article-title":"Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions","volume":"69","author":"Harrison, D.G.; Ferguson, D.W.; Collins, S.M.; Skorton, D.J.; Eriksen, E.E.; Kioshos, J.M.","year":"1984","unstructured":"Harrison DG, Ferguson DW, Collins SM, Skorton DJ, Eriksen EE, Kioshos JM, et al. Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions. Circulation 1984;69:991-9.","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/01.CIR.80.5.1159","article-title":"Recurrent ischaemia without warning. Analysis of risk factors for in hospital ischaemic events following successful thrombolysis with intravenous tissue plasminogen activator","volume":"80","author":"Ellis, S.G.; Topol, E.J.; George, B.S.; Kereiakes, D.J.; Debowey, D.; Sigmon, K.N.","year":"1989","unstructured":"Ellis SG, Topol EJ, George BS, Kereiakes DJ, Debowey D, Sigmon KN et al. Recurrent ischaemia without warning. Analysis of risk factors for in hospital ischaemic events following successful thrombolysis with intravenous tissue plasminogen activator. Circulation 1989;80:1159-65.","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomised trials","volume":"27","author":"Yusuf, S.; Peto, R.; Lewis, J.; Collins, R.; Sleight, P.","year":"1985","unstructured":"Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomised trials. Prog Cardiovasc Dis 1985;27:335-71.","journal-title":"Prog Cardiovasc Dis"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/hrt.50.3.266","article-title":"Significance of haemodynamic variables in coronary care unit for prediction of survival after acute myocardial infarction","volume":"50","author":"Wolffenbuttel, B.H.R.; Verdouw, P.D.; Scheffer, M.G.; Bom, H.P.A.; Bijleveld, R.E.; Hugenholtz, P.G.","year":"1983","unstructured":"Wolffenbuttel BHR, Verdouw PD, Scheffer MG, Bom HPA, Bijleveld RE, Hugenholtz PG. Significance of haemodynamic variables in coronary care unit for prediction of survival after acute myocardial infarction. Br Heart J 1983;50:266-72.","journal-title":"Br Heart J"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0002-8703(87)90014-7","article-title":"Prediction of 1 year outcome after complicated and uncomplicated myocardial infarction: Bayesian analysis of predischarge exercise test results in 300 patients","volume":"113","author":"Deckers, J.W.; Fioretti, P.; Brower, R.W.; Baarman, T.; Beelen, A.; Simoons, M.L.","year":"1987","unstructured":"Deckers JW, Fioretti P, Brower RW, Baarman T, Beelen A, Simoons ML. Prediction of 1 year outcome after complicated and uncomplicated myocardial infarction: Bayesian analysis of predischarge exercise test results in 300 patients. Am HeartJ 1987;113:90-8.","journal-title":"Am HeartJ"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0002-9149(83)90114-5","article-title":"Long term prognosis after first Q wave (transmural) or non-Q wave (nontransmural) myocardial infarction: analysis of 593 patients","volume":"52","author":"Krone, R.J.; Friedman, E.; Thanavaro, S.; Miller, J.P.; Kleiger, R.E.; Oliver, G.C.","year":"1983","unstructured":"Krone RJ, Friedman E, Thanavaro S, Miller JP, Kleiger RE, Oliver GC. Long term prognosis after first Q wave (transmural) or non-Q wave (nontransmural) myocardial infarction: analysis of 593 patients. Am J Cardiol 1983;52:234-9.","journal-title":"Am J Cardiol"},{"key":"ref_17","first-page":"986","article-title":"Subendocardial and transmural myocardial infarction. A five year study","volume":"66","author":"Frabicius-Bjerre, N.; Munkvad, M.; Knudsen, J.B.","year":"1979","unstructured":"Frabicius-Bjerre N, Munkvad M, Knudsen JB. Subendocardial and transmural myocardial infarction. A five year study. AmJMed 1979;66:986-93.","journal-title":"AmJMed"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/hrt.57.4.313","article-title":"Prognostic stratification of patients after myocardial infarction","volume":"57","author":"Murray, D.P.; Salih, M.; Tan, L.B.; Murray, R.G.; Littler, W.A.","year":"1987","unstructured":"Murray DP, Salih M, Tan LB, Murray RG, Littler WA. Prognostic stratification of patients after myocardial infarction. Br Heart J 1987;57: 313-8.","journal-title":"Br Heart J"},{"key":"ref_19","first-page":"98","article-title":"Limitations on the prognostic value of predischarge data after myocardial infarction","volume":"60","author":"Cleempoel, H.; Vainsel, H.; Dramaix, M.; Lenaers, A.; Contu, E.; Hoylaerts, M.","year":"1988","unstructured":"Cleempoel H, Vainsel H, Dramaix M, Lenaers A, Contu E, Hoylaerts M, et al. Limitations on the prognostic value of predischarge data after myocardial infarction. BrHeartJ 1988;60:98-103.","journal-title":"BrHeartJ"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/01.CIR.59.6.1124","article-title":"Prognosis after acute myocardial infarction: a multivariate analysis of mortality and survival","volume":"59","author":"Henning, H.; Gilpin, E.A.; Covell, W.; Swan, E.A.; O'Rourke, R.A.; Ross, J.","year":"1979","unstructured":"Henning H, Gilpin EA, Covell W, Swan EA, O'Rourke RA, Ross J. Prognosis after acute myocardial infarction: a multivariate analysis of mortality and survival. Circulation 1979;59:1124-30.","journal-title":"Circulation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0002-9149(88)90918-6","article-title":"Short term risk stratification at admission based on simple clinical data in acute myocardial infarction","volume":"61","author":"Dubois, C.; Pierard, L.A.; Albert, A.; Smeets, J.-P.; Demoulin, J.-C.; Boland, J.","year":"1988","unstructured":"Dubois C, Pierard LA, Albert A, Smeets J-P, Demoulin J-C, Boland J, et al. Short term risk stratification at admission based on simple clinical data in acute myocardial infarction. AmJCardiol 1988;61:216-9.","journal-title":"AmJCardiol"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM198205063061801","article-title":"Determinants of prognosis in survivors of myocardial infarction. A prospective clinical angiographic study","volume":"306","author":"Sanz, G.; Castaner, A.; Betrui, A.; Magrina, J.; Roig, E.; Coll, S.","year":"1982","unstructured":"Sanz G, Castaner A, Betrui A, Magrina J, Roig E, Coll S, et al. Determinants of prognosis in survivors of myocardial infarction. A prospective clinical angiographic study. NEnglJ'Med 1982;306:1065-70.","journal-title":"NEnglJ'Med"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0002-9149(84)90003-1","article-title":"Prognosis after recovery from first acute myocardial infarction: determinants of reinfarction and sudden death","volume":"53","author":"Norris, R.M.; Barnaby, P.F.; Brandt, P.W.T.; Geary, G.G.; Whitlock, R.M.L.; Wild, C.J.","year":"1984","unstructured":"Norris RM, Barnaby PF, Brandt PWT, Geary GG, Whitlock RML, Wild CJ, et al. Prognosis after recovery from first acute myocardial infarction: determinants of reinfarction and sudden death. Am J Cardiol 1984;53: 408-13.","journal-title":"Am J Cardiol"},{"key":"ref_24","first-page":"1353","article-title":"Improvement in long term survival among patients hospitalised with acute myocardial infarction, 1970 to 1980","volume":"316","author":"true","year":"1987","unstructured":"Gomez-Marin 0, Folsom AR, Kottke TE, Shu-Chen H, Jacobs DR, Gillum RF, et al. Improvement in long term survival among patients hospitalised with acute myocardial infarction, 1970 to 1980. The Minnesota Heart Survey. NEnglJMed 1987;316:1353-9.","journal-title":"The Minnesota Heart Survey. NEnglJMed"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/01.CIR.68.5.961","article-title":"Long term prognosis after recovery from myocardial infarction: a nine year followup ofthe Perth Coronary Register","volume":"68","author":"Martin, C.A.; Thompson, P.L.; Armstrong, B.K.; Hobbs, M.S.T.; de Klerk, N.","year":"1983","unstructured":"Martin CA, Thompson PL, Armstrong BK, Hobbs MST, de Klerk N. Long term prognosis after recovery from myocardial infarction: a nine year followup ofthe Perth Coronary Register. Circulation 1983;68:961-9.","journal-title":"Circulation"},{"key":"ref_26","first-page":"176","article-title":"Five year survival of 728 patients after myocardial infarction. A community study","volume":"43","author":"Pohjola, S.; Siltanen, P.; Romo, M.","year":"1980","unstructured":"Pohjola S, Siltanen P, Romo M. Five year survival of 728 patients after myocardial infarction. A community study. BrHearty 1980;43:176-83.","journal-title":"BrHearty"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/01.CIR.85.4.1254","article-title":"Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analysis of patient subgroups in the thrombolysis in myocardial infarction (TIMI) trial, phase II","volume":"85","author":"Mueller, H.S.; Cohen, L.S.; Braunwald, E.; Formen, S.; Feit, F.; Ross, A.","year":"1992","unstructured":"Mueller HS, Cohen LS, Braunwald E, Formen S, Feit F, Ross A, et al. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analysis of patient subgroups in the thrombolysis in myocardial infarction (TIMI) trial, phase II. Circulation 1992;85: 1254-64.","journal-title":"Circulation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/0735-1097(89)90003-X","article-title":"Long term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity","volume":"14","author":"Simoons, M.L.; Vos, J.; Tijssen, J.G.P.; Vermeer, F.; Verheugt, F.W.A.; Krauss, H.","year":"1989","unstructured":"Simoons ML, Vos J, Tijssen JGP, Vermeer F, Verheugt FWA, Krauss H, et al. Long term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of the Netherlands. J Am Coll Cardiol 1989;14: 1609-15.","journal-title":"Cardiology Institute of the Netherlands. J Am Coll Cardiol"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.CIR.76.1.44","article-title":"End-systolic volume as the major determinant of survival after recovery from myocardial infarction","volume":"76","author":"White, H.D.; Norris, R.M.; Brown, M.A.; Brandt, P.W.T.; Whitlock, R.M.L.; Wild, C.J.","year":"1987","unstructured":"White HD, Norris RM, Brown MA, Brandt PWT, Whitlock RML, Wild CJ. End-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.","journal-title":"Circulation"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0735-1097(92)90134-9","article-title":"Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the intemational tissue plasminogen activator streptokinase mortality trial","volume":"20","author":"Barbash, G.I.; White, H.D.; Modan, M.; Van der Werf, F.","year":"1992","unstructured":"Barbash GI, White HD, Modan M, Van der Werf F. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the intemational tissue plasminogen activator streptokinase mortality trial. JAm Coll Cardiol 1992;20:36-41.","journal-title":"JAm Coll Cardiol"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0735-1097(90)90583-B","article-title":"Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking","volume":"16","author":"Rivers, J.T.; White, H.D.; Cross, D.B.; Williams, B.F.; Norris, R.M.","year":"1990","unstructured":"Rivers JT, White HD, Cross DB, Williams BF, Norris RM. Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking. J Am Coil Cardiol 1990;16:340-8.","journal-title":"J Am Coil Cardiol"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.307.6900.349","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.307.6900.349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T18:51:08Z","timestamp":1766429468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.307.6900.349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,8,7]]},"references-count":31,"journal-issue":{"issue":"6900","published-online":{"date-parts":[[1993,8,7]]},"published-print":{"date-parts":[[1993,8,7]]}},"alternative-id":["10.1136\/bmj.307.6900.349"],"URL":"https:\/\/doi.org\/10.1136\/bmj.307.6900.349","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,8,7]]}}}